Reversal of competitive neuromuscular blockade by RX 67668 in normal volunteers.
D001285:Atropine / Q000494:pharmacology; D001828:Body Image / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D003510:Cyclohexanes / Q000009:adverse effects / Q000494:pharmacology*; D004558:Electric Stimulation; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D011759:Pyrrolidines / Q000009:adverse effects / Q000494:pharmacology*; D014403:Tubocurarine / Q000037:antagonists & inhibitors*
D002800:Cholinesterase Inhibitors; D003510:Cyclohexanes; D011759:Pyrrolidines; D009388:Neostigmine; D001285:Atropine; D014403:Tubocurarine